| Symbol | IPHA |
|---|---|
| Name | INNATE PHARMA SA |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 117 AVENUE DE LUMINY, MARSEILLE, None 13009 |
| Telephone | 33430303030 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001598599 |
| Description | None |
New Form SCHEDULE 13G/A - Innate Pharma SA <b>Filed:</b> 2026-06-22 <b>AccNo:</b> 0000950103-26-009261 <b>Size:</b> 6 KB
Read moreInnate Pharma - Innate Pharma to participate in the Jefferies Global Healthcare Conference
Read moreInnate Pharma to participate in the Jefferies Global Healthcare Conference
Read moreInnate Pharma - Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
Read moreInnate Pharma Reports First Quarter 2026 Business Update and Financial Results
Read moreInnate Pharma - Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
Read moreInnate Pharma - Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
Read more